MoneyWorks4Me

Nectar Lifesciences informs about outcome of board meeting

28 Nov 2020 Evaluate
Nectar Lifesciences has informed that pursuant to Reserve Bank India had vide its circulars permitted one-time restructuring for the accounts which were standard as on march 01, 2020, the Board of Directors in its meeting held on today have decided to opt for the one-time restructuring of its debt and authorised the officers of the company to discuss and/ or finalize the one-time restructuring plan with the banks/ financial institutions and/ or to sign any agreement, document application or paper as is required to accomplish the said one-time restructuring.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

12.10 -0.39 (-3.12%)
01-Sep-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1930.45
Dr. Reddys Labs. 1171.00
Cipla 1418.00
Lupin 2150.00
Zydus Lifesciences 1164.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: